Supernus Pharmaceuticals (SUPN) Net Margin Growth (5y) (2016 - 2025)
Supernus Pharmaceuticals (SUPN) Net Margin Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Supernus Pharmaceuticals | 2.72 Bn | 2.34 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,337.00 |
| Sep 30, 2025 | -4,927.00 |
| Mar 31, 2025 | -3,055.00 |
| Dec 31, 2024 | -2,418.00 |
| Sep 30, 2024 | -632.00 |
| Jun 30, 2024 | -1,944.00 |
| Mar 31, 2024 | -2,136.00 |
| Dec 31, 2023 | -2,162.00 |
| Sep 30, 2023 | -3,758.00 |
| Jun 30, 2023 | -3,149.00 |
| Mar 31, 2023 | -1,812.00 |
| Dec 31, 2022 | -20.00 |
| Sep 30, 2022 | -1,887.00 |
| Jun 30, 2022 | -1,828.00 |
| Mar 31, 2022 | -108.00 |
| Dec 31, 2021 | 4,420.00 |
| Sep 30, 2021 | -9,431.00 |
| Jun 30, 2021 | -307.00 |
| Mar 31, 2021 | -657.00 |
| Dec 31, 2020 | 575.00 |